The PBC Carve-Out: Delaware Chancery Just Rewrote the Rules for Public Benefit Corporations in Change-of-Control Deals

In a decision that should send ripples through every M&A practice advising mission-driven companies, the Delaware Court of Chancery ruled on July 29, 2026, that public benefit corporations are not required to maximize sale price in a change-of-control transaction the way traditional corporations are. The ruling, reported by Reuters, represents one of the most consequential corporate-governance decisions of the year — and it arrives at a moment when the PBC form is finally moving from boutique experiment to mainstream deal structure.

What the Court Actually Held

The Chancery judge held that PBCs — entities formed under 8 Del. C. § 362 that are statutorily required to balance stockholder pecuniary interests with a stated public benefit purpose — operate under a fundamentally different fiduciary framework when a sale or change of control is on the table. Traditional corporations, of course, are subject to the enhanced scrutiny of Revlon, Inc. v. MacAndrews & Forbes Holdings, Inc., 506 A.2d 173 (Del. 1986), which requires directors to obtain the highest value reasonably available for stockholders once a sale becomes inevitable.

The Chancery decision carves PBCs out of that mandate. Directors of a PBC, the court reasoned, may weigh the public benefit purpose alongside — and potentially above — pure price maximization when evaluating competing bids or deciding whether to sell at all. This is not a marginal tweak. It is a structural departure from the doctrinal architecture that has governed Delaware M&A for four decades.

Why This Matters More Than You Think

Since Delaware amended its General Corporation Law in 2013 to authorize PBCs, the form has attracted a growing roster of high-profile adopters — from consumer brands to technology companies seeking to hardwire ESG commitments into their corporate DNA. But a persistent question has haunted practitioners: What happens to the public benefit mission when the company is sold? Could a PBC board accept a lower bid from a buyer committed to preserving the mission over a higher bid from one that isn't?

Before this ruling, the conventional wisdom among deal lawyers was that Revlon applied with equal force to PBCs, meaning boards had little practical room to favor mission-aligned bidders at the expense of price. The concern was not academic. It created a structural disincentive for founders and investors considering the PBC form — why adopt a mission-driven charter if Delaware law would force you to abandon it at the exit?

The Chancery court has now answered that question, and the answer is: the mission survives the sale process.

The Doctrinal Tension

Let's be clear about what this decision does to the existing framework. Under Revlon and its progeny — including Paramount Communications Inc. v. QVC Network Inc., 637 A.2d 34 (Del. 1994) — the board's obligation in a change-of-control context is singular: get the best price. The court's PBC ruling introduces a multi-factor analysis where the board must balance pecuniary returns against the corporation's stated public benefit purpose, consistent with the tri-partite fiduciary structure embedded in § 362(a).

This is not a watering down of fiduciary duties. It is a recognition that PBC fiduciaries operate under a different statutory mandate — one that Delaware's own General Assembly created and that courts are now obligated to honor.

But the decision raises immediate questions. How much weight must directors give to the public benefit purpose relative to price? Is there a floor below which a PBC board cannot go in sacrificing stockholder value for mission preservation? And critically, does this ruling create a new category of fiduciary-duty litigation where plaintiffs challenge PBC boards for privileging mission over value — or vice versa?

Practical Implications for Dealmakers

For PBC boards: The ruling provides meaningful cover to consider non-price factors in a sale process, but it does not eliminate the obligation to articulate a rational basis for the board's decision. Expect enhanced scrutiny — just not Revlon scrutiny — and expect plaintiffs' firms to test the boundaries of this new standard aggressively.

For buyers: If you are acquiring a PBC, understand that you may not win on price alone. A competing bidder willing to commit to the target's public benefit mission may have a structural advantage that no amount of additional consideration can overcome. Deal protection provisions — no-shop clauses, termination fees, matching rights — take on heightened importance in this context.

For founders and investors considering the PBC form: This decision removes one of the most significant legal uncertainties that has suppressed PBC adoption. The form now offers genuine protection for mission-driven governance through the full corporate lifecycle, including at exit.

The Broader Context

This ruling does not exist in a vacuum. It arrives alongside a wave of Delaware M&A litigation — including the ongoing Silver Lake v. Icahn hedge funds appraisal dispute over the Endeavor buyout and the $250 million Activision settlement awaiting approval from Chief Judge Kathaleen McCormick — that collectively signals a Chancery Court actively reshaping the boundaries of fiduciary obligation in complex transactions.

The PBC decision, in particular, reflects a court willing to take Delaware's statutory innovations seriously rather than forcing novel corporate forms into doctrinal boxes designed for a different era. That is a welcome development — and one that should accelerate the PBC form's migration from the margins to the mainstream of American corporate practice.